ArticleFrontiers in oncology2022

Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.

Arsela Prelaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.